| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Cohen Neil Harris is a Director at Chemomab Therapeutics Ltd.. Recent SEC Form 4 filings include 6 buys and 1 sell.
Estimated insider holdings value: $18K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | CMMB Chemomab Therapeutics Ltd. | Director | Sell | 2,409 | $2.00 | $4,818.00 | -19.4% | -9.2% | -71.1% | |
| May 18, 2022 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 2,000 | $3.19 | $6,380.00 | +19.2% | +21.9% | -39.9% | |
| Mar 14, 2022 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 6,000 | $4.35 | $26,120.00 | +31.2% | -15.4% | -62.5% | |
| Dec 6, 2021 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 2,000 | $7.43 | $14,860.00 | +83.0% | -52.5% | -73.6% | |
| Mar 16, 2021 | CMMB Chemomab Therapeutics Ltd. | Director | Buy | 2,409 | $41.51 | $99,997.59 | New | -70.7% | -94.4% |